Daniel Charytonowicz
Impact in
-
- Antibiotic Resistance in Bacteria
-
- Long-Term Effects of COVID-19
Papers in
- Oncology 3
- Lung Cancer Research Studies 1
-
- Cancer Genomics and Diagnostics 1
- Co-authors
- Robert Sebra (5 shared papers)Rachel Brody (1 shared paper)Christopher J. Panebianco (1 shared paper)James C. Iatridis (1 shared paper)Ed Wilson (1 shared paper)Matthew Jonathan Murray (1 shared paper)Nicholas Coleman (1 shared paper)José Silva (1 shared paper)
- Journals
- Stroke (1 paper)Cancer Cell (1 paper)Journal of Neuroinflammation (1 paper)Clinical Genitourinary Cancer (1 paper)Cell (1 paper)
- Partner nations
- United StatesAustraliaTaiwan
In The Last Decade
Daniel Charytonowicz
12 papers receiving 328 citations
Peers
Comparison fields: 5 of 68
- Molecular Medicine 24
- Neurology 52
- Biological Psychiatry 6
- Infectious Diseases 43
- Neurology 16
Countries citing papers authored by Daniel Charytonowicz
This map shows the geographic impact of Daniel Charytonowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Charytonowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Charytonowicz more than expected).
Fields of papers citing papers by Daniel Charytonowicz
This network shows the impact of papers produced by Daniel Charytonowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Charytonowicz. The network helps show where Daniel Charytonowicz may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Charytonowicz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 76 | |
| 2 | 2020 | 66 | |
| 3 | 2024 | 59 | |
| 4 | 2021 | 36 | |
| 5 | 2023 | 28 | |
| 6 | 2019 | 27 | |
| 7 | 2023 | 14 | |
| 8 | 2012 | 13 | |
| 9 | 2013 | 6 | |
| 10 | 2024 | 5 | |
| 11 | 2025 | 3 | |
| 12 | 2024 | 1 |
About Daniel Charytonowicz
Daniel Charytonowicz is a scholar working on Oncology, Cancer Research, Biological Psychiatry, Immunology and Developmental Neuroscience, having authored 12 papers that have together received 334 indexed citations. Recurring topics across this work include Single-cell and spatial transcriptomics (2 papers), Tryptophan and brain disorders (1 paper), COVID-19 Clinical Research Studies (1 paper), Cancer Genomics and Diagnostics (1 paper), TGF-β signaling in diseases (1 paper), Lung Cancer Research Studies (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Molecular Medicine (24 citations), Neurology (52 citations), Biological Psychiatry (6 citations), Infectious Diseases (43 citations) and Neurology (16 citations). Daniel Charytonowicz has collaborated with scholars based in United States, Australia and Taiwan. Frequent co-authors include Robert Sebra, Rachel Brody, Christopher J. Panebianco, James C. Iatridis, Ed Wilson, Matthew Jonathan Murray, Nicholas Coleman, José Silva, Tian Huai Shen and Mireia Castillo-Martín. Their work appears in journals such as Stroke, Cancer Cell, Journal of Neuroinflammation, Clinical Genitourinary Cancer and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.